Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 5,760 | 4,707 | 4,707 | 387 | 4,882 |
| Cost of Goods | 248 | 259 | 259 | 225 | 141 |
| Gross Profit | 5,512 | 4,448 | 4,448 | 162 | 4,741 |
| Operating Expenses | 9,807 | 5,988 | 5,988 | 3,069 | 7,013 |
| Operating Income | -4,047 | -1,281 | -1,281 | -2,682 | -2,131 |
| Interest Expense | 8,714 | 8,612 | 8,612 | 23 | 5,525 |
| Other Income | -5,575 | -7,463 | -7,463 | 0 | 22,225 |
| Pre-tax Income | -18,336 | -17,356 | -17,356 | -2,704 | 14,569 |
| Income Tax | 56 | 52 | 52 | 37 | N/A |
| Net Income Continuous | -18,392 | -17,408 | -17,408 | -2,704 | 14,569 |
| Minority Interests | N/A | N/A | N/A | -327 | N/A |
| Net Income | $-18,392 | $-17,408 | $-17,408 | $-2,378 | $14,569 |
| EPS Basic Total Ops | -0.40 | -0.46 | -0.46 | -1.92 | 0.40 |
| EPS Basic Continuous Ops | -0.40 | -0.46 | -0.46 | -2.15 | 0.40 |
| EPS Diluted Total Ops | -0.40 | -0.46 | -0.46 | -1.92 | -0.13 |
| EPS Diluted Continuous Ops | -0.40 | -0.46 | -0.46 | -2.15 | 0.40 |
| EBITDA(a) | $10,577 | $-1,281 | $6,024 | $-15,729 | $10,823 |